arrow
C

Charles B.L.M. Majoie

University of Amsterdam
H指数:90
被引数:5.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correlation of Thrombus Immune Cell Composition and Clinical Outcome in Acute Ischemic Stroke: A MR CLEAN-NO IV sub-study

急性缺血性卒中血栓免疫细胞组成与临床结局的相关性:一项MR CLEAN-NO IV亚组研究

2026-08-310
OAAI
Tranexamic acid after aneurysmal subarachnoid hemorrhage is associated with worse outcome in males: post hoc analysis of the ULTRA trial

Tranexamic酸在动脉瘤性蛛网膜下腔出血后与男性预后较差相关:ULTRA试验的事后分析

2026-08-190
OA
Machine learning models for CT-based classification of ischemic stroke onset time within or beyond 4.5 h: a comparison of approaches

基于CT的缺血性卒中发病时间(4.5小时内或超出4.5小时)分类的机器学习模型:方法比较

2025-12-080
PRE
Cost-Effectiveness of Ultra-Early Tranexamic Acid as Add-On to Standard Care After Subarachnoid Hemorrhage (ULTRA Trial)

超早期氨甲环酸作为蛛网膜下腔出血后标准护理的附加治疗的经济性分析(ULTRA试验)

2025-08-220
OAAI
CT Perfusion Imaging After Selection for Late-Window Endovascular Stroke Treatment Secondary Analysis of the MR CLEAN-LATE Randomized Trial

MR CLEAN-LATE随机试验的晚期时间窗脑血管内卒中治疗筛选后的CT灌注成像二次分析

2025-06-010
PRE
Arterial collateral status and treatment effect of intravenous alteplase thrombolysis prior to endovascular treatment in patients with anterior circulation large vessel occlusion: prespecified analysis of the MR CLEAN-NO IV trial

前循环大血管闭塞患者中,在行血管内治疗前静脉阿替普酶溶栓的动脉侧支状态和治疗效应:MR CLEAN-NO IV试验的预先设定分析

2025-05-240
PRE
National trends in patient characteristics, interventional techniques and outcomes of endovascular treatment for acute ischaemic stroke: Final results of the MR CLEAN Registry (2014-2018)

急性缺血性卒中经导管血管内治疗的患者特征、干预技术和结局的全国趋势:MR CLEAN Registry(2014-2018)的最终结果

2025-05-020
PRE
Cerebral blood flow and cognitive functioning in patients undergoing transcatheter aortic valve implantation

经导管主动脉瓣植入术患者的脑血流与认知功能

2025-03-011
PRE
Modified Rankin Scale at 90 Days Versus National Institutes of Health Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials

90天时改良Rankin量表与24小时时美国国立卫生研究院卒中量表作为急性卒中试验的主要结局

2025-02-190
OAAI
Carotid Artery Stenting during Endovascular treatment of acute ischemic Stroke (CASES) study protocol for a multicenter randomized clinical trial
2025-02-160
PRE
Modified Rankin Score at 90 Days vs. NIH Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials

90天改良Rankin评分与24小时NIH卒中量表作为急性卒中试验的主要结局指标

STROKE
IF8.9
2025-02-010
PRE
Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma
2024-11-211
PRE